Search Results - "Chu, F.I."

History and Development of Clinical Use of Functional Stereotaxy for Radiation Oncologists: From Its Origins to Its Current State.

Authors: Goulet, Merrik Masucci, Giuseppina Laura Taussky, Daniel et al.

Source: Current Oncology. Dec2025, Vol. 32 Issue 12, p656. 20p.

A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase.

Authors: Wright, Jessica A. White, Stephanie D. Frame, Gavin et al.

Source: Cells (2073-4409). Jun2025, Vol. 14 Issue 11, p819. 20p.

Hypofractionated Radiotherapy for Soft Tissue Sarcomas.

Authors: Zerey, Mehmet Murat Gul, Amna Kalman, Noah S. et al.

Source: Cancers. Apr2025, Vol. 17 Issue 7, p1170. 10p.

Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.

Authors: Duque-Santana, Victor Fernandez, Julio Diaz-Gavela, Ana et al.

Source: Cancers. Mar2025, Vol. 17 Issue 5, p762. 15p.

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis.

Authors: Kubeš, Jiri Sláviková, Silvia Vítek, Pavel et al.

Source: Cancers. Sep2023, Vol. 15 Issue 18, p4571. 10p.

Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus Erythematosus.

Authors: Schenker, Hannah Kuhlmann, Lukas Kaudewitz, Dorothee et al.

Source: Cells (2073-4409). Apr2025, Vol. 14 Issue 8, p569. 18p.

Modification of RNF183 via m6A Methylation Mediates Podocyte Dysfunction in Diabetic Nephropathy by Regulating PKM2 Ubiquitination and Degradation.

Authors: Guo, Dongwei Pang, Yingxue Wang, Wenjie et al.

Source: Cells (2073-4409). Mar2025, Vol. 14 Issue 5, p365. 25p.

Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial.

Authors: Heesen, Philip Di Lonardo, Michele Ciobanu-Caraus, Olga et al.

Source: Cancers. Dec2024, Vol. 16 Issue 23, p4063. 10p.

Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic Model.

Authors: Wang, Hanzhi Gong, Linsey Huang, Xiaoyong et al.

Source: Cancers. Aug2024, Vol. 16 Issue 16, p2839. 20p.

Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.

Authors: González-del-Alba, Aránzazu Martínez Ballesteros, Claudio Arranz, José Ángel et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3208. 23p.

Diversity and Seasonal Abundance of Culicoides (Diptera: Ceratopogonidae) in Tengchong County of Yunnan, China.

Authors: Wang, Yi-Nan Duan, Ying-Liang Li, Zhan-Hong et al.

Source: Insects (2075-4450). Aug2025, Vol. 16 Issue 8, p780. 19p.

Optimizing Treatment Precision: Role of Adaptive Radiotherapy in Modern Anal Cancer Management.

Authors: Horowitz, David P. Wang, Yi-Fang Lee, Albert et al.

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2478. 15p.

Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.

Authors: Westley, Rosalyne Casey, Francis Mitchell, Adam et al.

Source: Cancers. Jun2024, Vol. 16 Issue 11, p2073. 15p.

Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion.

Authors: De Bari, Berardino Guibert, Geoffroy Slimani, Sabrine et al.

Source: Current Oncology. Feb2024, Vol. 31 Issue 2, p962-974. 13p.

From Intensification to Optimization: Balancing Efficacy, Safety, and Costs in High-Risk Localized Soft Tissue Sarcomas.

Authors: Fuchs, Bruno Schelling, Georg Glanzmann, Christoph et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1724. 19p.

Treatment Optimization in Linac-Based SBRT for Localized Prostate Cancer: A Single-Arc versus Dual-Arc Plan Comparison.

Authors: Panizza, Denis Faccenda, Valeria Arcangeli, Stefano et al.

Source: Cancers. Jan2024, Vol. 16 Issue 1, p13. 11p.

Diagnostic Performance of 99m Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18 F-PSMA-1007 PET/CT.

Authors: Vargas-Ahumada, Joel E. González-Rueda, Sofía Denisse Sinisterra-Solís, Fabio Andrés et al.

Source: Cancers. Dec2023, Vol. 15 Issue 24, p5824. 13p.

Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis.

Authors: Schröder, Christina Mose, Lucas Mathier, Etienne et al.

Source: Cancers. Dec2023, Vol. 15 Issue 24, p5815. 10p.

Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials.

Authors: Riviere, Paul Dornisch, Anna M. Sanghvi, Parag et al.

Source: Cancers. Dec2023, Vol. 15 Issue 23, p5550. 11p.

The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer.

Authors: Drobner, Jake Kaldany, Alain Shah, Mihir S. et al.

Source: Cancers. Jul2023, Vol. 15 Issue 14, p3734. 14p.